| Product Code: ETC13177521 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Rotavirus Prophylaxis Market was valued at USD 0.82 Billion in 2024 and is expected to reach USD 1.2 Billion by 2031, growing at a compound annual growth rate of 5.40% during the forecast period (2025-2031).
The Global Rotavirus Prophylaxis Market is witnessing steady growth driven by the increasing awareness about the importance of vaccination in preventing rotavirus infections, particularly in children. The market is characterized by the availability of oral rotavirus vaccines such as Rotarix and RotaTeq, which have been proven to be highly effective in reducing the incidence and severity of rotavirus gastroenteritis. The rising investments in healthcare infrastructure and government initiatives to introduce vaccination programs in developing countries are further fueling market expansion. Key players in the market include GlaxoSmithKline, Merck & Co., Inc., and Bharat Biotech. Ongoing research and development activities aimed at developing new and improved prophylactic measures against rotavirus are expected to drive market growth in the coming years.
The Global Rotavirus Prophylaxis Market is witnessing significant growth due to the increasing awareness about rotavirus infections and the introduction of advanced vaccines. Rising healthcare expenditure, expanding immunization programs, and the growing emphasis on preventive healthcare are driving market growth. The market is also benefiting from the rising infant population in developing countries and the increasing adoption of rotavirus vaccines in routine immunization schedules. Additionally, technological advancements in vaccine development and distribution channels are creating opportunities for market players. However, challenges such as high costs associated with vaccines, limited access to healthcare in remote regions, and vaccine hesitancy among some populations could hinder market growth. Overall, the market is poised for expansion, with key players focusing on product innovation and strategic partnerships to capitalize on emerging opportunities.
The Global Rotavirus Prophylaxis Market faces several challenges, including limited awareness about the availability and benefits of rotavirus vaccines in certain regions, particularly in low- and middle-income countries. Additionally, high costs associated with vaccine development, production, and distribution can hinder access to prophylaxis for vulnerable populations. Regulatory hurdles, such as approval processes and compliance requirements, also pose challenges for manufacturers and healthcare providers. Moreover, vaccine hesitancy and misinformation about the safety and efficacy of rotavirus vaccines can impact adoption rates and hinder efforts to control the spread of the virus. Addressing these challenges requires collaborative efforts among healthcare organizations, governments, manufacturers, and advocacy groups to improve access, education, and affordability of rotavirus prophylaxis globally.
The global rotavirus prophylaxis market is primarily driven by the increasing awareness about the benefits of vaccination in preventing rotavirus infections, especially in children. The rising incidence of rotavirus-induced diarrhea and related complications, coupled with the growing emphasis on immunization programs by governments and healthcare organizations worldwide, are significant factors fueling market growth. Additionally, the development of advanced vaccines with improved efficacy and safety profiles, along with the expansion of vaccination coverage in emerging economies, are contributing to the expansion of the rotavirus prophylaxis market. The focus on reducing healthcare costs associated with rotavirus infections and the continuous research and development efforts to introduce novel prophylactic solutions further drive market growth.
Government policies related to the Global Rotavirus Prophylaxis Market primarily focus on promoting the use of rotavirus vaccines to prevent the spread of the virus among children. Many governments around the world have included rotavirus vaccination in their national immunization programs to reduce the burden of rotavirus-related illnesses and deaths. Some countries also provide subsidies or incentives to healthcare providers and parents to increase the vaccine coverage rate. Additionally, regulatory bodies closely monitor the safety and efficacy of rotavirus vaccines to ensure public health and safety. Overall, government policies aim to increase awareness about the importance of rotavirus vaccination and make the vaccines more accessible to the population, especially in low-income countries where the burden of rotavirus infections is significant.
The Global Rotavirus Prophylaxis Market is expected to witness significant growth in the coming years due to the increasing awareness about rotavirus infection and the importance of vaccination in preventing it. With advancements in healthcare infrastructure and rising investments in research and development, new and more effective prophylaxis options are likely to enter the market, driving further growth. Additionally, the expanding pediatric population in developing countries, where rotavirus infection poses a significant health risk, will contribute to market expansion. Government initiatives to promote vaccination programs and the growing focus on preventive healthcare will also fuel market growth. Overall, the Global Rotavirus Prophylaxis Market is projected to experience steady growth in the foreseeable future.
In the global Rotavirus Prophylaxis market, Asia is anticipated to witness significant growth due to improving healthcare infrastructure and increasing awareness about rotavirus vaccination programs. North America is expected to dominate the market with a high adoption rate of vaccine products and favorable reimbursement policies. Europe is projected to show steady growth due to government initiatives promoting vaccination and rising incidences of rotavirus infections. Middle East and Africa are likely to witness moderate growth owing to increasing investments in healthcare and a growing focus on preventive healthcare measures. Latin America is poised for growth due to expanding vaccination coverage and efforts to reduce the burden of rotavirus-related diseases in the region. Overall, the market is expected to experience substantial growth across all regions driven by increasing awareness and efforts to control rotavirus infections.
Global Rotavirus Prophylaxis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Rotavirus Prophylaxis Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Rotavirus Prophylaxis Market Revenues & Volume, 2021 & 2031F |
3.3 Global Rotavirus Prophylaxis Market - Industry Life Cycle |
3.4 Global Rotavirus Prophylaxis Market - Porter's Five Forces |
3.5 Global Rotavirus Prophylaxis Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Rotavirus Prophylaxis Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Global Rotavirus Prophylaxis Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Global Rotavirus Prophylaxis Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Global Rotavirus Prophylaxis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Rotavirus Prophylaxis Market Trends |
6 Global Rotavirus Prophylaxis Market, 2021 - 2031 |
6.1 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Rotarix, 2021 - 2031 |
6.1.3 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Rotavac, 2021 - 2031 |
6.1.4 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Rotavin-M1, 2021 - 2031 |
6.1.5 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Lanzhou Lamb, 2021 - 2031 |
6.1.6 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Oral Rehydration Fluid, 2021 - 2031 |
6.1.7 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.2.4 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Rotavirus Prophylaxis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.3.4 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.3.5 Global Rotavirus Prophylaxis Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Rotavirus Prophylaxis Market, Overview & Analysis |
7.1 North America Rotavirus Prophylaxis Market Revenues & Volume, 2021 - 2031 |
7.2 North America Rotavirus Prophylaxis Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Rotavirus Prophylaxis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
7.4 North America Rotavirus Prophylaxis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Rotavirus Prophylaxis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8 Latin America (LATAM) Rotavirus Prophylaxis Market, Overview & Analysis |
8.1 Latin America (LATAM) Rotavirus Prophylaxis Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Rotavirus Prophylaxis Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Rotavirus Prophylaxis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
8.4 Latin America (LATAM) Rotavirus Prophylaxis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.5 Latin America (LATAM) Rotavirus Prophylaxis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9 Asia Rotavirus Prophylaxis Market, Overview & Analysis |
9.1 Asia Rotavirus Prophylaxis Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Rotavirus Prophylaxis Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Rotavirus Prophylaxis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
9.4 Asia Rotavirus Prophylaxis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.5 Asia Rotavirus Prophylaxis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10 Africa Rotavirus Prophylaxis Market, Overview & Analysis |
10.1 Africa Rotavirus Prophylaxis Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Rotavirus Prophylaxis Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Rotavirus Prophylaxis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
10.4 Africa Rotavirus Prophylaxis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.5 Africa Rotavirus Prophylaxis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11 Europe Rotavirus Prophylaxis Market, Overview & Analysis |
11.1 Europe Rotavirus Prophylaxis Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Rotavirus Prophylaxis Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Rotavirus Prophylaxis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
11.4 Europe Rotavirus Prophylaxis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.5 Europe Rotavirus Prophylaxis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12 Middle East Rotavirus Prophylaxis Market, Overview & Analysis |
12.1 Middle East Rotavirus Prophylaxis Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Rotavirus Prophylaxis Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Rotavirus Prophylaxis Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Rotavirus Prophylaxis Market, Revenues & Volume, By Treatment, 2021 - 2031 |
12.4 Middle East Rotavirus Prophylaxis Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.5 Middle East Rotavirus Prophylaxis Market, Revenues & Volume, By End-Users, 2021 - 2031 |
13 Global Rotavirus Prophylaxis Market Key Performance Indicators |
14 Global Rotavirus Prophylaxis Market - Export/Import By Countries Assessment |
15 Global Rotavirus Prophylaxis Market - Opportunity Assessment |
15.1 Global Rotavirus Prophylaxis Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Rotavirus Prophylaxis Market Opportunity Assessment, By Treatment, 2021 & 2031F |
15.3 Global Rotavirus Prophylaxis Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.4 Global Rotavirus Prophylaxis Market Opportunity Assessment, By End-Users, 2021 & 2031F |
16 Global Rotavirus Prophylaxis Market - Competitive Landscape |
16.1 Global Rotavirus Prophylaxis Market Revenue Share, By Companies, 2024 |
16.2 Global Rotavirus Prophylaxis Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |